Product screening
Antibodies
Proteins
MADD Polyclonal Antibody
Alias:MADD;DENN;IG20;KIAA0358;MAP kinase-activating death domain protein;Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor
CatalogNo:HJRLT2620
Specifications
50μL;100μL
Delivery date
Spot
Target
MADD
Reactivity
Human,Mouse,Rat
Application - After Update
WB,IHC,IF,ELISA
MW(Observed)
183kD
Host Species
Rabbit
Isotype
IgG
Modify
Unmodified
Recommended dilution ratio
WB 1:500-1:2000;IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:5000;Not yet tested in other applications.
compose
Liquid in PBS containing 50％ glycerol, 0.5％ BSA and 0.02％ sodium azide.
Store
-15°C to -25°C/1 year（Do not lower than -25°C）
Soncentration
1 mg/ml
Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human MADD. AA range:751-800
Specificity
MADD Polyclonal Antibody detects endogenous levels of MADD protein.
Gene name
MADD
Protein name
MAP kinase-activating death domain protein
Organism-1
Human